Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

National MS Society funds research for earlier disease detection

The National Multiple Sclerosis Society is inviting researchers across a broad range of disciplines to apply for a new funding opportunity focused on advancing earlier detection of multiple sclerosis (MS).

6 Nov 2026

Tau spreads more rapidly in early-onset Alzheimer's disease

Patients with early-onset Alzheimer's disease, whose symptoms start before age 65, have more extensive deposits of tau, a hallmark protein of the condition, compared with patients whose symptoms start at 65-plus, a new study found.

5 Nov 2026

Brain scans reveal clues to Alzheimer's risk years before memory loss begins

Inside the brains of some cognitively normal adults, firing patterns were able to foretell Alzheimer's disease years before the onset of memory loss or the accumulation of plaques and tangles, according to new Stanford Medicine-led research.

5 Nov 2026

Modern lifestyles may be changing our gut bacteria in unexpected ways

A global study of 1,015 adults across 12 countries found that industrialized lifestyles were associated with lower gut bacterial diversity, reduced microbial community stability, and increased markers of intestinal stress and immune activity. The researchers also found that a microbiome-based health index developed using industrialized populations performed poorly in less-industrialized communities, raising concerns about its applicability across diverse populations.

4 Nov 2026

DHA improves autism-like behaviors in a preclinical rat study

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition marked by social and communication difficulties and repetitive behaviors.

3 Nov 2026

Compounds that give citrus fruits their scent may affect gut health

A review published in Food & Function found that dietary terpenoids, naturally occurring compounds in fruits, herbs, and vegetables, can suppress inflammatory signalling and improve intestinal barrier function in laboratory and animal studies. However, human evidence remains limited to two small studies of geraniol-based interventions for irritable bowel syndrome, with further research needed to establish clinical efficacy, appropriate dosing, and long-term safety.

3 Nov 2026

Nanoparticle structural design improves disease biomarker detection sensitivity

A nanoparticle's performance depends on more than what it is made of-it can also depend on how its building blocks are arranged.

3 Nov 2026

Mount Sinai receives NIH grant to study advanced MRI methods for locating seizures

Researchers at the Icahn School of Medicine at Mount Sinai have received more than $3 million from the National Institutes of Health (NIH) for a five-year study of advanced magnetic resonance imaging (MRI) methods that may help locate seizure-causing brain regions in people with drug-resistant epilepsy.

2 Nov 2026

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory Journal (ERJ).

From Qureight 2 Nov 2026

Eating walnuts was linked to higher IgG levels, but what does that mean for health?

A two-year randomized trial involving 474 older adults found that daily consumption of 30–60 grams of walnuts was associated with 6% higher total serum IgG concentrations compared with a control diet, with an 11% difference observed among US participants. Walnut consumption did not significantly affect IgM, MDA-LDL or MDA-LDL-specific antibodies, and whether the modest IgG difference has meaningful cardiovascular benefits remains unknown.

1 Nov 2026

Hemoadsorption may improve outcomes in severe poisoning cases

The WHO estimated over 800,000 suicide deaths in 2012, with poisoning a major concern. Three‑quarters of suicides occur in low‑ and middle‑income countries, with an estimated 30% related to pesticides.

30 Oct 2026

Study redefines picobirnavirus as a bacteria hunting virus

Thriving alongside trillions of bacteria in the human digestive tract is a vast population of viruses. Ever since one such denizen of the gut microbiome, known as picobirnavirus, was first spotted decades ago, researchers thought it directly infected human tissue and played a role in gastrointestinal illness.

29 Oct 2026

Limited app use adds a twist to a nurse-led dementia risk trial

A cluster-randomized trial involving 403 Australian adults aged 45–65 found that a 12-month nurse-led behavioral intervention supported by a mobile app modestly improved estimated dementia risk scores compared with brief counseling and usual care. The study found no significant improvements in cognitive performance or other secondary outcomes, leaving its long-term effects on dementia prevention uncertain.

28 Oct 2026

Ulcerative colitis burden across 7MM to exceed 2.36 million cases by 2035, forecasts GlobalData

The diagnosed prevalent cases of ulcerative colitis (UC) in the seven major markets (7MM) are projected to reach over 2.36 million by 2035.

28 Oct 2026

NIOX® launches NIOX PRO®, their next generation FeNO testing device

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.

From NIOX Group PLC 28 Oct 2026

Low-power implantable neural chip tracks communication across brain regions

Deep brain stimulation (DBS) is a therapeutic technique that delivers electrical pulses to specific areas of the brain via an implant to modulate neural activity.

23 Oct 2026

Blood biomarker test improves detection of hidden brain injuries

Clinician-scientists hope to expand the use of blood-based biomarker tests for traumatic brain injury (TBI) to improve identification and escalation of care for patients whose diagnosis otherwise might be missed.

23 Oct 2026

What can 6,000 brain scans tell us about Alzheimer's?

KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain structure to cognitive performance.

23 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

$8.2 million grant advances on-demand male contraceptive development

Weill Cornell Medicine has received a four-year, $8.2 million grant from the National Institute of Child Health and Human Development (NICHD) to develop and test an experimental on-demand male contraceptive pill that temporarily stops sperm in their tracks

22 Oct 2026